Quantum-Si appoints Jack Kenny to its Board of Directors

– USA, CT –  Quantum-Si Incorporated (Nasdaq: QSI), The Protein Sequencing Company, today announced the appointment of Jack Kenny to its Board of Directors, bringing more than 30 years of experience as a key executive leader within large public companies in the healthcare and medical device industries to this role.

About Jack Kenny

Jack Kenny has a proven track record of driving growth at Meridian Bioscience as CEO and serves on its board of directors. Previously, he was SVP and General Manager, of North America at Siemens Healthcare, and VP and GM of the U.S. Region for Diagnostic Systems at Becton Dickinson. Throughout his career, Mr. Kenny has held additional leadership positions of increasing responsibility for companies including Leica Microsystems, Quest Diagnostics, and Bayer Diagnostics. He earned a Bachelor of Science in management systems from Kettering University in Michigan.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

For more information: https://www.quantum-si.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.